Explore CD59 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]
| Target ID |
GM-T78552
|
| Target Name |
CD59
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
966
|
| Gene ID |
101092210 (Felis catus), 106781397 (Equus caballus), 25407 (Rattus norvegicus), 475945 (Canis lupus familiaris) 505574 (Bos taurus), 693402 (Macaca mulatta), 966 (Homo sapiens)
|
| Target Alternative Names |
16.3A5,1F5,1F5 antigen,20 kDa homologous restriction factor (HRF-20,CD59,CD59 glycoprotein,Cd59,Cd59a,Cd59b,EJ16,EJ30,EL32,G344,HRF-20,HRF20,HRF20),MAC-IP,MAC-inhibitory protein (MAC-IP),MACIF,MACIP,MEM43,MEM43 antigen,MIC11,MIN1,MIN2,MIN3,MIRL,MSK21,Membrane attack complex inhibition factor (MACIF),Membrane inhibitor of reactive lysis (MIRL),Protectin,p18-20
|
| Uniprot Accession |
P27274,P13987
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer, Ovary Cancer, Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic), Contrast - Induced Nephropathy, Dent disease, IgA glomerulonephritis, Ovarian cancer, Type 1 diabetes mellitus
|
| Disease from KEGG |
Complement and coagulation cascades, Hematopoietic cell lineage
|
| Gene Ensembl |
ENSECAG00000027924, ENSCAFG00845025193, ENSBTAG00000002302, ENSMMUG00000055602, ENSG00000085063
|
Pre-made viral vector of CD59 cDNA Clones/ORF Plasmid
CD59 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo966 | Pre-made Human CD59/1F5/EJ16 siRNA oligo Duplex | 966 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo25407 | Pre-made Rat Cd59b/Cd59/Cd59a siRNA oligo Duplex | 25407 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo693402 | Pre-made Cynomolgus/Rhesus macaque CD59 siRNA oligo Duplex | 693402 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101092210 | Pre-made Cat/Feline CD59 siRNA oligo Duplex | 101092210 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo475945 | Pre-made Dog/Canine CD59 siRNA oligo Duplex | 475945 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo505574 | Pre-made Bovines/Cattle CD59 siRNA oligo Duplex | 505574 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo106781397 | Pre-made Equine/Horse CD59 siRNA oligo Duplex | 106781397 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CD59 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T78552-Ab | Human | Anti-Human CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T78552-Ab | Rat | Anti-Rat CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T78552-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T78552-Ab | Cat/Feline | Anti-Cat/Feline CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T78552-Ab | Dog/Canine | Anti-Dog/Canine CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T78552-Ab | Bovines/Cattle | Anti-Bovines/Cattle CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T78552-Ab | Equine/Horse | Anti-Equine/Horse CD59 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CD59 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T78552-Ag | Human | Human CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T78552-Ag | Rat | Rat CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T78552-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T78552-Ag | Cat/Feline | Cat/Feline CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T78552-Ag | Dog/Canine | Dog/Canine CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T78552-Ag | Bovines/Cattle | Bovines/Cattle CD59 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T78552-Ag | Equine/Horse | Equine/Horse CD59 VLP (virus-like particle) | HEK293 | Products Developing |